Resources Contact Us Home
Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety

Image Number 13 for United States Patent #8119616.

The present invention relates to a composition comprising an inclusion complex of a cyclodextrin and quinazoline containing zinc-binding moiety based derivatives. The cyclodextrin is preferable a .beta.-cyclodextrin or a derivative thereof. The quinazolines have enhanced and unexpected properties as inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and their use in the treatment of EGFR-TK related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.

  Recently Added Patents
System and method for optimizing use of plug-in air conditioners and portable heaters
Uplink interference mitigation method and apparatus
Mobile terminal
Radio frequency power delivery system
Touch-sensitive device and communication device
Integrated disk driving module including a stepping motor integrally formed with a base unit
Methods and apparatus for dynamic identification (ID) assignment in wireless networks
  Randomly Featured Patents
Continuous mixing and injection of lime-fly ash slurry
Unitard for exercising purposes
Bezel grinding attachment for a dop stick holder
Micrometer gauge
Method and device for introducing liquid substances into the trunk of a plant
Fluid operated clutch disengaging apparatus
Apparatus and method for processing pulse waves
Phase and frequency re-lock in synchronous ethernet devices
Using GPS and ranging to determine relative elevation of an asset
Fault tolerant voltage regulator module circuit for supplying core voltage and cache voltage to a processor